Neuroscientific Biopharmaceuticals Limited announced the appointment of Dr. Alexandra Heaton as Director of Operations to support the upcoming clinical programs in Glaucoma and Neurodegenerative Diseases. Dr. Alexandra Heaton holds a PhD in Neuroscience (University of Western Australia) with her research work focused on anti-oxidative, anti-inflammatory and anti-apoptotic effects of dietary supplementation in the brain in addition to enhancing neuroplasticity, synaptogenesis and neural signalling. Prior to joining Neuroscientific Biopharmaceuticals, Alexandra had the role of US Client Engagement with Linear Clinical Research Ltd, focusing on attracting partnerships with US Biotechnology and Pharmaceutical companies.